Coukos G - Search Results

1

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G. Zhang L, et al. Among authors: coukos g. Cancer Res. 2003 Jun 15;63(12):3403-12. Cancer Res. 2003. PMID: 12810677

2

Chemotherapy resistance in ovarian cancer: new molecular perspectives.

Coukos G, Rubin SC. Coukos G, et al. Obstet Gynecol. 1998 May;91(5 Pt 1):783-92. doi: 10.1016/s0029-7844(98)00054-4. Obstet Gynecol. 1998. PMID: 9572231 Review.

3

Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer.

Coukos G, Makrigiannakis A, Kang EH, Caparelli D, Benjamin I, Kaiser LR, Rubin SC, Albelda SM, Molnar-Kimber KL. Coukos G, et al. Clin Cancer Res. 1999 Jun;5(6):1523-37. Clin Cancer Res. 1999. PMID: 10389942

4

Complete hydatidiform mole. A disease with a changing profile.

Coukos G, Makrigiannakis A, Chung J, Randall TC, Rubin SC, Benjamin I. Coukos G, et al. J Reprod Med. 1999 Aug;44(8):698-704. J Reprod Med. 1999. PMID: 10483540

5

Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy.

Randall TC, Coukos G, Wheeler JE, Rubin SC. Randall TC, et al. Among authors: coukos g. Gynecol Oncol. 2000 Jan;76(1):115-7. doi: 10.1006/gyno.1999.5654. Gynecol Oncol. 2000. PMID: 10620452 Free article.

6

Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.

Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL. Coukos G, et al. Cancer Gene Ther. 2000 Feb;7(2):275-83. doi: 10.1038/sj.cgt.7700130. Cancer Gene Ther. 2000. PMID: 10770637

7

Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.

Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL. Coukos G, et al. Clin Cancer Res. 2000 Aug;6(8):3342-53. Clin Cancer Res. 2000. PMID: 10955822

8

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH. Woo EY, et al. Among authors: coukos g. Cancer Res. 2001 Jun 15;61(12):4766-72. Cancer Res. 2001. PMID: 11406550

9

Gene therapy for ovarian cancer.

Coukos G, Rubin SC. Coukos G, et al. Oncology (Williston Park). 2001 Sep;15(9):1197-204, 1207; discussion 1207-8. Oncology (Williston Park). 2001. PMID: 11589066 Free article. Review.

10

Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation.

Blank SV, Rubin SC, Coukos G, Amin KM, Albelda SM, Molnar-Kimber KL. Blank SV, et al. Among authors: coukos g. Hum Gene Ther. 2002 Mar 20;13(5):627-39. doi: 10.1089/10430340252837224. Hum Gene Ther. 2002. PMID: 11916486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters